1. 1. Senser B, Koseoglu D, Ozcelik U, Kocagoz T, Gunalp A. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Microbiol. 2001;291(1):387-93. 2. May TB, Shinabarger D, Maharaj R, Kato J, Chu L, DeVault JD, et al. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev. 1991;4(2):191-206. 3. Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infec Dis. 2000;19(12):915-25. 4. Cobb LM, Mychaleckyj JC, Wozniak DJ, López-Boado YS. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol. 2004;173(9):5659-70. 5. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005;171(11):1209-23. 6. Alaghebandan R, Rossignol AM, Rastegar Lari A. Pediatric Burn Injuries in Tehran, Iran. Burns. 2001;27(2):115-8. 7. Darvishpour A, Lotfi M, Salehi F, Aghazadeh A, Hasani A, Ali N. Comparing Dressing With Silver Sulfadiazine and Nitrofurazone to the Pediatrice Ward in Tabriz. J of Guilan Univer of Med Science. 2006;15(60):42-6. 8. Panjeshahin MR, Rastegar Lari A, Talei A, Shamsnia J, Alaghehbandan R. Epidemiology and mortality of Burns in the South West of Iran. Burns 2001;27(3):219-26. 9. Sheikh Azadi A, Ghare Daghi J, Ghadyani MH. Investigate the epidemiology of burns biological death in Tehran in 2005. J of Forensic Medicine. 2006;12(3):151-7. 10. Van Delden C, Iglewski BH. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerging infectious diseases. Infect. 1998;4(4):551. 11. Ramos HC, Rumbo M, Sirard JC. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004;12(11):509-17. 12. Askarian M, Hosseini R, Kheirandish P. Incidence and Microorganisms Causing Nosocomial Infections in Ghotbeddin Burn Center of Shiraz, Iran. J Kerman University of Medical Sciences. 1996;2(10):65-70. 13. Qorbani F, Seifi B, Mohamadzade Sh, Zaree M. Evaluation of microbial agents that cause wound infections in hospitalized patients Ayatollah Mousavi Zanjan. J Nursing Research. 2012;22(2):65-72. 14. Zolfaqari M, Khodad Motlaq M, Aqaei S, Heydarpour A. Factor’s affecting bacterial infections after burns in Nekouei-Hedayati Qom hospital burn units. J of Qom University of Medical Sciences.2012;3(5):23-9. 15. Church D, Sameer E, Owen R, Brent W, Robert L. Burn Wound Infections. Clinical Microbiology Reviews. 2006;19(2):403-34. 16. Rastegar Lari A, Alaghehbandan R, Nikui R. Epidemiological study of 3341 burn Patients during three years in Tehran, Iran. Burns. 2000;26(1):49-53. 17. Sharma BR, Harish D, Singh VP, Bangar S. Septicemia as a cause of death in burns: an autopsy study. Burns. 2006;32(5):545-9. 18. Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infection in a burn intensive care unit. Burns. 1995;21(3):181-4. 19. Panjeshahin MR, Lari AR, Talei A, Shamsnia J, Alaghehbandan R. Epidemiology and mortality of Burns in The South West of Iran. Burns. 2001;27(3):219-26. 20. Rastegar Lari A , Alaghehbandan R. Nosocomial infection in an Iranian Burn care center. Burns. 2000;26(8):737-40. 21. Holder IA. Pseudomonas immunotherapy: A historical overview. Vaccine. 2004;22(7):831-9. 22. Maria D, Appleman, Howard B, Diane M, Citron, Peter NR, et al. In vitro activities of nontraditional antimicrobial against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother. 2000;44(4):1035-40. 23. Soltani K, Zand R and Mirghasemi A. Epidemiology and mortality of burns inTehran, Iran. Burns. 1998;24(4):325-8. 24. Mozingo DW, Pruitt BA . Infectious complications after burn injury. Curr Opin Surg Infect. 1999;11(2):69-75. 25. Oussalah M, Caillet S, Saucier L, Lacroix M. Inhibitory effects of selected plant essential oils on the growth of four pathogenic bacteria: E.coli 0157:H7, Salmonella Typhimurium, Staphylococcus aureus and Listeria monocytogenes. Food Control. 2007;18(1): 414-20. 26. Abbasi A, Bahador A, Esmaeili D, Mahbubi A, Amiri M, Amiri M. The Study of Inhibitory Effects of Satureja khuzestanica against MDR Isolates of Pseudomonas aeruginosa. International J of Current Microbiology and Applied Sciences. 2014;2(3):614-8. 27. Deans SG, Svoboda KP. Antibacterial activity of summer savory (Satureja Khortensis L) essential oil and its constituents. J Hortic. Sci. 1989;64(1):205-10. 28. Jalalvandi N, Bahador A, Zahedi B, Saghi H, Esmaeili D. The study of inhibitory effects of Satureja khuzestanica essence against MEXA and MEXR efflux genes of pseudomonas aeruginosa by RT-PCR. The International J of Biotechnology. 2015;4(1):1-8. 29. Manohar V, Ingram C, Gray J, Talpur NA, Echard BW, Bagchi D, Preuss G. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001;228(1):111-7. 30. Leung AY, Foster S. Encyclopedia of common natural ingredients used in food drugs and cosmetics. 1996. 31. Jafari S, Amanlou M, Borhan-Mojabi K, Farsam H. Comparative study of Zataria multiflora and Anthemis nobelis extracts with Myrthus communis preparation in the treatment of recurrent Aphthous stomatitis. DARU J of Pharmaceutical Sciences. 2003;11(1):23-7. 32. Lange BM, Croteau R. Genetic engineering of essential oil production in mint. In Plant Biotechnology. 1999;2(1):139-44. 33. Moreno L, Bello R, Primo–Yufera E, Esplugues J. Pharmacological properties of the methanol extract from Mentha suaveolens Ehrh. Phytotherapy Research. 2002;16(1):10-3. 34. Hosseinzadeh H, Ramazani M, Salmani G. Antinociceptive, anti-inflammartory and acute toxicity effects of Zataria multiflora Boiss extracts in mice and rats. J of ethnopharmacology. 2000;73(3):379-85. 35. Shafiee A, Javidnia K, Tabatabai M. Volatile constituents and antimicrobial activity of Zataria multaflora, population Iran. Iranian J of Chemistry and Chemical Engineering. 1999;18(1):1-5. 36. Molan PC. The antimicrobial activity of honey. J Bee world. 1992;73(1):5-28. 37. Subrahmanyam M. Tropical application of honey in treatment of burns. British J of Surgery. 1991;78(4): 497–8. 38. Miorin PL, Levy Jonior NC, Custidio AR, Bretz WA, Marcucci MC. Anibactrial activity of honey and propolis from Apis mellifera and Tetragonisca angustula against Staphylococcus aureus. J Applied Microbial. 2003;95(5):913-20. 39. Ishii R, Horie M, Murayama Maitani T. Analysis of chloramphenicol in honey and royal jelly by LC/MS/MS. Shokuhin Eiseigaku Zasshi. 2006;47(2):58-65. 40. Pang GF, Cao YZ, Zhang JJ, Jia GQ, Fan CL, LI XM, et al. Simultaneous determination of 16 sulfonamides in honey by liquid chromatography/tandem mass spectrometry. J AOAC Int, 2005; 88(5): 1304-11. 41. Oka H, Improvement of chemical analysis of antibiotics; simultaneous analysis of seven tetracyclines in honey. J chromatogar. 1987;400(1): 253-61. 42. Mato L, Huidobro JF, Simal – Lozano J, Sancho MT. Rapid determination of nonaromatic organic acides in honey by capillary zone electrophoresis with direct ultraviolet detection. J Agric Food Chem. 2006;54(5):1541-50. 43. Rahmanian M, khuhestani A, Qavifekr H, Ter-Sarkissian N, Donoso G, Olszyna Marzys AO. High ascorbic acid content in some Iranian honeys. Chemical and Biological assayes. J Nutr Metab. 1970;12(1):131-5. 44. Nosal Nalda MJ, Bernal Yague JL, Gomez MT, Jimenes Sevilla JJ, Bernal del Nosal J, Higes Pascual M. Trace analysis of antibacterialtylosin A, B, C and D in honey by liquid chromatography – electrospray ionization- mass spectrometry. J Sep Sci. 2006;29(3):405-13. 45. Sardari S, Amin G, Micetich RG, Daneshtalab M. Phytopharmaceuticals. Part 1. Antifungal activity of selected Iranain and Canadian plants. Pharmaceutical Biology. 1998;36(3):180-8. 46. Amanlou M. Efficacy of satureja khuzistanica extract and its essential oil preparations in the management of recurrent aphthous stomatitis. DARU. 2007;15(4):231-5. 47. Khairy EA, Hedia RH, Dorgham SM, Effat M. Comparative studies on antimicrobial activities (AMA) of different types of honey using bacteria from animal origin. International J of Microbiological Research. 2013;4(1):5-50. 48. Dorman HJD, Deans SG. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J Appl Microbiol. 2000;88(2):308-16. 49. Mehrabian S, Bavandi R, Mohammadian Z. Comparative study of the chemical composition and antimicrobial activity of honey in some parts of Iran. J of Basic Science (Islamic Azad University). 2004;14(51):4235-43. 50. Yavarpour V, Zarabi M, Esmaeili D, Mohamad nejad. In vitro Evaluation of Antibacterial Efficacy of Natural Honeys in Comparisonwith Antibiotics on Pseudomonas aeruginosa. Iranian J of Medical Microbiology. 2014;8(1):31-4. 51. Mullai V, Menon T. Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa. J Altern Complement Med. 2007;13(4):439-41. 52. Safari M, Taqizade M, Pour Babaei M. Study the effects of different types of honey on the standard strains of Pseudomonas aeruginosa in vitro. J of Rafsanjan University of Medical Sciences. 2006;5(3):181-6. 53. Ansari M, Alizadeh AM, Paknejad M, Naeimi M. Effects of Teucrium Polium Honey on Burn Wound Healing Process. J of Babol University of Medical Sciences. 2009;11(3):7-12.